Lianyungang, China

Shanliang Zhu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shanliang Zhu. Retrieved from https://idiyas.com/inventor/shanliang-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Shanliang Zhu: Advancements in Pharmaceutical Crystals

Introduction

Shanliang Zhu, a dedicated inventor from Lianyungang, China, has made a significant contribution to the field of medicine through his innovative work on crystals of quinoline derivatives. His expertise in this area is exemplified by his patent that focuses on enhancing the pharmaceutical industry's capabilities.

Latest Patents

Zhu holds a patent for "Crystals of quinolone derivatives," which addresses an essential need in the medical field. This patent details the formation of crystals from quinoline derivative anhydrides and solvates. The innovation includes a production method that boasts high yield, mild crystallization conditions, and suitability for industrial-scale production. This advancement enables the pharmaceutical sector to better meet its demands and boosts efficiency in drug development.

Career Highlights

As a prominent member of Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Shanliang Zhu has established a successful career centered around pharmacological research and development. His work has emphasized the importance of innovation in drug formulations, contributing to the company's reputation as a leader in the pharmaceutical industry.

Collaborations

Throughout his career, Zhu has collaborated with esteemed colleagues, including Xiquan Zhang and Shanchun Wang. These partnerships have facilitated the exchange of ideas and expertise, leading to further advancements in pharmaceutical sciences and more effective contributions to medicine.

Conclusion

In summary, Shanliang Zhu's work exemplifies the critical role of inventors in advancing medical science. His patent on crystals of quinoline derivatives demonstrates his commitment to improving pharmaceutical products and processes. As he continues to work within Chia Tai Tianqing Pharmaceutical Group Co., Ltd. alongside his skilled colleagues, the impact of his innovations is sure to resonate throughout the industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…